◼ Archived Business 🔮 Newsylist predicts: still trending tomorrow medium confidence — graded ✗ wrong

Novartis’ TREM2 drug fails Phase 2 ALS trial

Name: Trend velocity series: Novartis’ TREM2 drug fails Phase 2 ALS trial
Creator: Newsylist

6sources

6articles

4velocity

+0%since first seen

5d agofirst detected

Text:

The coverage curve

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📊 AUDIENCE & LONGEVITY PULSE

Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.

ALS Phase Novartis TREM2

🔥 Breakout ↑ Rising Business

10 sources 10 articles v 8 7m ago

↑ Rising Business

10 sources 10 articles v 8 7m ago

▲ Peaking Business

9 sources 9 articles v 7 1h ago

↑ Rising Business

11 sources 12 articles v 10 1h ago

↓ Cooling Business 🔮 holds

10 sources 10 articles v 8 10h ago

↑ Rising Business 🔮 holds

11 sources 11 articles v 9 7m ago